Quantification and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC

Biomedical Chromatography

Volumn 19, Issue 8, 2005, Pages 570-578

  Arzuaga, A ^a   Isla, A ^a   Gascon A R ^a   Maynar, J ^b   Martin A ^b   Solinis M A ^a   Toral, D ^c   Pedraz Munoz J L ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL TXAGORRITXU   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Continuous hemofiltration; HPLC; Piperacillin; Stability; Tazobactam

Indexed keywords

DICHLOROMETHANE; DRUG PRODUCTS; PLASMA STABILITY; PROTEINS; QUALITY CONTROL;

CONTINUOUS HEMOFILTRATION; HEMOFILTRATION; HPLC; HPLC METHOD; PIPERACILLIN; PLASMA SAMPLES; PROTEIN PRECIPITATION; SAMPLE PREPARATION; SIMPLE++; TAZOBACTAM;

ACETONITRILE;

ACETONITRILE; AMIKACIN; BUFFER; DICHLOROMETHANE; ENOXAPARIN; METHANOL; MIDAZOLAM; MORPHINE; NORADRENALIN; OMEPRAZOLE; PENICILLIN G; PHOSPHATE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RANITIDINE; TAZOBACTAM; TAZOCEL; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; PENICILLANIC ACID;

ACCURACY; ARTICLE; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STABILITY; FREEZING; HEMOFILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRECIPITATION; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; THAWING; ULTRAFILTRATION; ULTRAVIOLET RADIATION; BLOOD; METHODOLOGY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ANTI-BACTERIAL AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEMOFILTRATION; HUMANS; PENICILLANIC ACID; PIPERACILLIN; SENSITIVITY AND SPECIFICITY; ULTRAFILTRATION;

EID: 26844518437     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.482     Document Type: Article

References (21)

1. Aravind MK, Miceli JN and Kauffman RE. Analysis of piperacillin using high-performance liquid chromatography. Journal of Chromatography A 1982; 233: 423-426.
2. Arzuaga A, Maynar J, Gascón AR, Isla A, Corral E, Fonseca F, Sánchez-Izquierdo JA, Rello J, Canut A and Pedraz JL. Influence of renal function on the pharmacokinetics of piperacillin /tazobactam in ICU patients during CVVH. Journal of Clinical Pharmacology 2005; 45(2): 168-176.
3. Augey V, Grosse PY, Albert G, Audran M and Bressolle F. High-performance liquid chromatographic determination of tazobactam and piperacillin in human plasma and urine. Journal of Chromatography B 1996; 682(1): 125-136.
4. Campanero MA, Zamarreño AM, Simón M, Dios MC and Azanza JR. Simple and rapad determination of piperacillin and ceftazidime in human plasma samples by HPLC. Chromatographia 1997; 46 (7/8): 374-380.
5. De Schepper, Tjandramaga TB, Mullie A, Verbesselt R, van Hecken A, Verberckmoes R and Verbist L. Comparative pharmacokinetics of piperacillin in normals and in patients with renal failure. Journal of Antimicrobial Chemotherapy 1982; 9 (suppl. B): 49-57.
6. DeSilva B, Smith W, Weiner R, Kelley M, Smolec JM, Lee B, Khan M, Tacey R, Howard H and Abbie C. Recommendations for the bioanalytical method validation of ligand-binding assay to support pharmacokinetic assessments of macromolecules. Pharmaceutical Research 2003; 20(11): 1885-1900.
7. FDA. Guidance for Industry, Bioanalytical Method Validation. Center for Drug Evaluation and Research (CDER), Food and Drug Administration, Rockville, MD 2001.
8. García-Glez JC, Méndez R and Martín-Villacorta J. Determination of piperacillin and mezlocillin in human serum and urine by high-performance liquid chromatography alter derivatisation with 1,2,4-triazole. Journal of Chromatography A 1998; 812: 213-220.
9. George CRP, Burgoyne J, Funnell GR, Robinson P, Collignon P, Meads K et al. Pharmacokinetics of piperacillin in renal failure. Medical Journal of Australia 1981; 1: 35-6.
10. López ML, Baño MD and Guillén JL. Long-term stability of methadone in clinical plasma samples stored at -20°C. Journal of Analytical Toxicology 2002; 26; 4: 236-238.
11. Mathew M, Das Gupta V and Bethea C. Stability of piperacillin sodium in the presence of tazobactam sodium in 5% dextrose and normal saline injections. Journal of Clinical Pharmaceutical Therapy 1994; 19: 397-399.
12. McCormack JP, Cooper J and Carleton B. Simple approach to dosage adjustment in patients with renal impairment. American Journal of Health - Systematic Pharmacy 1997; 54: 2505-2509.
13. Ocampo AP, Hoyt KD, Wadgaonkar, Carver AH and Puglisi CV. Determinaiton of tazobactam and piperacillin in human plasma, serum, bile and urine by gradient elution reversed-phase high-performance liquid chromatography. Journal of Chromatography B 1989; 496(1): 167-179.
14. Occhipinti DJ, Pendland SL, Schoonover LL, Rypins EB, Danziger LH and Rodvold KA. Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens. Antimicrobial Agents and Chemotherapy 1997; 41(11): 2511-2517.
15. Perry CM and Markham A. Piperacillin/tazobactam. An updated review of its use in the treatment of bacteria infections. Drugs 1999; 57: 805-843.
16. Peyrin E, Guillaume Y and Guinchard C. High-performance liquid chromatographic determinaiton of tazobactam by precolumn derivatisation. Journal of Chromatography B 1995; 672: 160-164.
17. Reed MD, Goldfarb J and Yamashita TS. Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children. Antimicrobial Agents and Chemotherapy 1994; 38: 2817-2826.
18. Sörgel F and Kinzig M. The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam. Journal of Antimicrobial Chemotherapy 1993; 31(suppl. A): 39-60.
19. Ventura R, Jimenez C, Closas N, Segura J and De la Torre R. Stability studies of selected doping agents in urine: caffeine. Journal of Chromatography B 2003; 795: 167-177.
20. Whitaker GW and Lindstrom TD. Determination of LY217332, a new 3′-quaternary ammonium cephalosporin, in plasma by solid phase column extraction and HPLC. Journal of Liquid Chromatography 1988; 11(4): 901-912.
21. Zarzuelo A, López FG, Santos M and Lanao JM. Determination of piperacillin in biological samples by HPLC. Journal of Liquid Chromatography and Related Technology 1996; 19(4): 601-610.